Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXZ51V
|
||||
Drug Name |
[2-Butoxy-5-(3,4-dihydro-2H-quinoline-1-sulfonyl)-phenyl]-bis-(3H-imidazol-4-ylmethyl)-amine
|
||||
Synonyms |
CHEMBL93624
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H32N6O3S
|
||||
Canonical SMILES |
CCCCOc1ccc(cc1N(Cc2c[nH]cn2)Cc3c[nH]cn3)S(=O)(=O)N4CCCc5ccccc45
|
||||
InChI |
InChI=1S/C27H32N6O3S/c1-2-3-13-36-27-11-10-24(37(34,35)33-12-6-8-21-7-4-5-9-25(21)33)14-26(27)32(17-22-15-28-19-30-22)18-23-16-29-20-31-23/h4-5,7,9-11,14-16,19-20H,2-3,6,8,12-13,17-18H2,1H3,(H,28,30)(H,29,31)
|
||||
InChIKey |
JFZMOETXFDBLKQ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.